tirzepatide google scholar Cardiovascular outcomes of semaglutide and for patients with type 2 diabetes in clinical practice Comparative safety and side effects

Review Article Abstract Introduction Retatrutide for Treatment of Obesity Retatrutide for Treatment of Type 2 Diabetes Effects of Retatrutide on Cardiovascular Risk Factors Safety of Retatrutide Effect of Retatrutide on Heart Rate Advantages of Retatrutide Limitations of Retatrutide Conclusions and Current Needs References Effect of Retatrutide on Heart Rate Increase in heart rate, of approximately 2-6 beats per minute (bpm) compared with placebo, was observed with use of all GLP-1 receptor agonists and with the dual GLP-1/GIP receptor agonist tirzepatide [6-11]

Type 1 error was controlled across multiple tests

Note: 15mg of Zinc is 150% of your daily recommended intake

Jiang, Y., Zhang, G., Wang, J